Acasti Pharma Inc. (ACST)
NASDAQ: ACST
· Real-Time Price · USD
3.37
0.13 (4.01%)
At close: Oct 25, 2024, 10:00 PM
Acasti Pharma Ratios and Metrics
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
PE Ratio | -5.06 | -1.98 | -2.51 | -3.05 | -2.56 | -2.25 | -1.61 | -1.47 | -0.18 | -1.43 | -1.31 | -2.11 | -3.46 | -3.69 | 16.71 | -9.36 |
PEG Ratio | 0.04 | -0.1 | -0.1 | 0.10 | -0.41 | 0.09 | 0.08 | 0.02 | -0.00 | 0.07 | -0.16 | -0.16 | -0.59 | 0.01 | -0.13 | 0.21 |
PS Ratio | 8.20 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -641.27 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.60 | 0.72 | 0.61 | 0.54 | 0.53 | 0.33 | 0.31 | 0.37 | 0.30 | 0.23 | 0.26 | 0.37 | 0.50 | 0.50 | 0.57 | 2.18 |
P/FCF Ratio | -43.56 | -6.13 | -8.14 | -8.87 | -14.77 | -11.36 | -9.95 | -3.79 | -6.15 | -5.99 | -7.51 | -7.02 | -17.18 | -12.17 | -10.74 | -34.31 |
P/OCF Ratio | -44.64 | -6.11 | -8.14 | -8.87 | -14.92 | -11.36 | -9.95 | -3.79 | -6.17 | -5.99 | -7.51 | -7.03 | -17.18 | -12.17 | -10.74 | -34.31 |
OCF/S Ratio | -0.18 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 103.94 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
Quick Ratio | 11.77 | 6.06 | 6.01 | 7.86 | 14.26 | 15.19 | 20.68 | 12.01 | 8.59 | 9.74 | 9.86 | 11.61 | 13.97 | 16.91 | 12.19 | 25.75 |
Current Ratio | 11.77 | 6.06 | 6.01 | 7.86 | 14.26 | 15.19 | 20.68 | 12.01 | 8.59 | 9.74 | 9.86 | 11.13 | 13.97 | 16.91 | 12.19 | 25.75 |
Asset Turnover | 0.07 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -41.68 | n/a | n/a | -21.12 | n/a | -12.76 | -13.4 | -33.24 | -295.68 | n/a | -141.89 | n/a | -45.58 | n/a | n/a | -22.63 |
Return on Equity | -0.03 | -0.09 | -0.06 | -0.04 | -0.05 | -0.04 | -0.05 | -0.06 | -0.43 | -0.04 | -0.05 | -0.04 | -0.04 | -0.03 | 0.01 | -0.06 |
Return on Assets | -0.03 | -0.08 | -0.05 | -0.04 | -0.04 | -0.03 | -0.04 | -0.06 | -0.37 | -0.03 | -0.04 | -0.04 | -0.03 | -0.03 | 0.01 | -0.05 |
Return on Invested Capital | 0.72 | n/a | -0.06 | -0.06 | -0.05 | -0.05 | -0.03 | -0.06 | -0.06 | -0.05 | -0.04 | -0.05 | -0.01 | -0.04 | -0.03 | -0.05 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 441.09 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | -0.41 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 908.97 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | -0.08 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.6K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | 2.03 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 175.56 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -0.13 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 129.88 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |